Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (25)

2023

  1. High rates of colonization by Staphylococcus aureus in medical students before doing their clinical practices

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 251-253

2022

  1. Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli

    Medical Microbiology and Immunology, Vol. 211, Núm. 5-6, pp. 269-272

2020

  1. Synergy of linezolid with several antimicrobial agents against linezolid-methicillin-resistant staphylococcal strains

    Antibiotics, Vol. 9, Núm. 8, pp. 1-13

2017

  1. Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

2015

  1. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains

    International Journal of Antimicrobial Agents

2014

  1. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: High percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 460-464

2013

  1. Aumento significativo de la colonización por Staphylococcus aureus entre los estudiantes de medicina durante la realización de las prácticas en el hospital

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 8, pp. 516-519

  2. Aumento significativo de la resistencia a fosfomicina en cepas de escherichia coli productoras de β-lactamasas de espectro extendido (BLEE) aisladas de urocultivos (2005-2009-2011)

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 43-46

2012

  1. Klebsiella pneumoniae: Development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient

    Clinical Microbiology and Infection, Vol. 18, Núm. 1, pp. 61-66

2010

  1. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli in Madrid, Spain

    Diagnostic Microbiology and Infectious Disease, Vol. 67, Núm. 4, pp. 380-383

2007

  1. Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain

    International Journal of Antimicrobial Agents

2006

  1. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates

    International Journal of Antimicrobial Agents, Vol. 27, Núm. 4, pp. 303-306

2005

  1. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: Antimicrobial susceptibility patterns in different groups of species

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 2, pp. 820-823

  2. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: Decreased susceptibility to 6 fluoroquinolones

    Diagnostic Microbiology and Infectious Disease

2003

  1. Antibiotic resistance and clinical significance of Haemophilus influenzae type f

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 961-966

  2. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid

    International Journal of Antimicrobial Agents, Vol. 21, Núm. 6, pp. 536-541

2002

  1. Incidencia y factores de riesgo de hepatitis A en la provincia de Guadalajara

    Gastroenterología y hepatología, Vol. 25, Núm. 4, pp. 230-234

2001

  1. Prevalencia de hepatitis A en la provincia de Guadalajara. ¿Es España un país de baja endemia?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 9, pp. 428-431

1998

  1. Resistencia intrínseca de Haemophilus influenzae a los betalactámicos

    Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 52-59

1991

  1. RESISTENCIA DE H. INFLUENZAE. REPERCUSION TERAPEUTICA: ANTIBIOTICOS CONVENCIONALES Y NUEVAS OPCIONES

    Revista Espanola de Quimioterapia